aplastic anemia | Page 13 | Aplastic Anemia & MDS International Foundation

aplastic anemia

Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years

Author(s): 
Sheth VS, Potter V, Gandhi SA, Kulasekararaj AG, de Lavallade H, Muus P, Pagliuca A, Rice CFM, Mehra V, Grimaldi F, Inam S, Barber LD, Mufti GJ, Marsh JC
Primary Author: 
Sheth VS
Journal Title: 
Blood Advances
Original Publication Date: 
Oct 2019

Survival after allogeneic hematopoietic cell transplantation (HSCT) for severe

Bone Marrow Diseases: 

Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia

Author(s): 
Bejanyan N, Kim S, Hebert KM, Kekre N, Abdel-Azim H, Ahmed I, Aljurf M, Badawy SM, Beitinjaneh A, Boelens JJ, Diaz MA, Dvorak CC, Gadalla S, Gajewski J, Gale RP, Ganguly S, Gennery AR, George B, Gergis U, Gómez-Almaguer D
Primary Author: 
Bejanyan N
Journal Title: 
Blood Advances
Original Publication Date: 
Oct 2019

Allogeneic bone marrow transplantation (BMT) is curative therapy for the treatment of patients with severe

Bone Marrow Diseases: 

Rabi Hanna, MD

Hanna, Rabi
Director of the Pediatric Bone Marrow Transplantation
The Cleveland Clinic Taussig Cancer Institute

Dr. Hanna is board certified in pediatrics and pediatric hematology-Oncology. He earned his medical degree from Aleppo University Faculty of Medicine in Aleppo, Syria. His post-graduate training in USA includes a pediatric residency at Duke University Medical Center in Durham, North Carolina, and a pediatric hematology-oncology fellowship at the Fred Hutchinson Cancer Research Center and Seattle Children’s Hospital in Seattle, Washington.

Elizabeth Griffiths, MD

Griffiths, Elizabeth
Associate Professor
Roswell Park Comprehensive Cancer Center

Dr. Griffiths am board certified in hematology, oncology and internal medicine and hold medical licenses in New York and Maryland. She is a member of multiple professional organizations, including the American Society of Hematology, the American Association for Cancer Research, the Society for Immunotherapy of Cancer and the American Society of Oncology.

Lucy Godley, MD, PhD

Godley, Lucy
Professor of Medicine
University of Chicago Duchossois Center for Advanced Medicine - Hyde Park

Lucy A. Godley, MD, PhD, is an expert in the care and treatment of patients with diseases of the bone marrow, including leukemias, lymphomas and multiple myeloma. She also cares for patients undergoing stem cell transplantation and patients with benign hematologic conditions.

Biju George, MD

George, Biju
Christian Medical College of Vellore, India

Dr. George is an a Clinician scientist involved in the management of patients with haematological disorders for the past 17 years. He completed my sub-specialty training (DM) in Clinical Haematology in 2002 at CMC Vellore under the guidance of Dr. Mammen Chandy. His thesis for DM in Clinical Haematology was studying the Profile of Infections in patients undergoing stem cell transplantation.